Amarin Corp Plc (AMRN)

[ilovetech]

North, first, my sincerest gratitude for your work, and I'm certain the entire board feels the same way. I think Pharmacydude has a valid point, however, my concern goes a step further. There's a long way to go before the market achieves acceptance of V, and even longer, before we see major shift away from cheaper inferior ulternatives. Physician market acceptance is miniscule, and continues to be challenging.

-Having multiple O3's lanch simultaneously would dilute, if not canabolize the effort to get the market aligned behind V.


-A bitter tasting real world sampling came to me recently: I was rattled after the ruling, knots to over my stomach, ensued by sweatballs from my temples. I had hoped my brother could console me out of dispair, however, when we met face to face, he looked so defeated, that the mere mention that Generics will infringe Reduce-it, he just wasn't having it. In the heat of the moment, he shared CardioMD's view that "Doctors don't care", "they will write Generics." When I pressed further, he said, a rep recently shared of being laughed out of physician offices for peddling fish oil".

* We need to have one exclusive high purity Vascepa product on the market. Otherwise, the education process will take much longer.

ILT